$8.03
0.151.84%
Last update: Oct 27, 12:47 PM
BioCryst Pharmaceuticals Inc (BCRX) Stock Price, Quote, News & History
BCRXNASDAQ
BioCryst will acquire Astria Therapeutics for $700 million to expand its HAE portfolio with navenibart, aiming for double-digit revenue growth.
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioCryst Pharma has a consensus price target of $20.71.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $8.025 last updated October 27, 2026 at 12:47 PM EDT.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple...
